Jessica Mueller, MD
Obstetrics & Gynecology · Kyle, TXNPI 1376868760
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.2% of the total across 21 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Roche Diagnostics Corporation at 27.3% of the total. Reporting peaked in 2019 at $215 and has fallen 59.8% since, to $86 in 2025. That places this record below the midpoint for obstetrics & gynecology clinicians in TX, where the typical reported total is $863.
Across 21 payments — averaging $21.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Roche Diagnostics Corporation$124
- Hologic Sales And Service, LLC$89
- AbbVie$44
- Sumitomo Pharma America, Inc.$40
- AMAG Pharmaceuticals, Inc.$35
- Exeltis, USA Inc.$24
- plus $99 from 7 others
What the payments were for
- Food & beverage$41992%
- Education$358%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Roche Diagnostics Corporation | 4 | $124 |
| Hologic Sales And Service, LLC | 3 | $89 |
| AbbVie | 2 | $44 |
| Sumitomo Pharma America, Inc. | 2 | $40 |
| AMAG Pharmaceuticals, Inc. | 2 | $35 |
| Exeltis, USA Inc. | 1 | $24 |
| Biogen | 1 | $21 |
| Astellas Pharma US Inc | 1 | $15 |
| Organon | 1 | $14 |
| Avion Pharmaceuticals | 1 | $14 |
| Mayne Pharma Commercial LLC | 1 | $12 |
| Lupin Inc. | 1 | $12 |
| Pfizer | 1 | $11 |
How this compares
$454 in reported general payments places this provider in the 35th percentile of 3,099 obstetrics & gynecology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 48 | $3,136 |
| Sumatriptan Succinate | 11 | $81 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Kyle
- Devin GarzaAustin$2M
- Shawn TassoneAustin$1.3M
- Dale StovallDallas$590K
- Karyn-Anne CumberbatchMissouri City$452K
- Robert AsgharianEl Paso$366K
- Catherine HansenWebster$357K
- Lisa JukesBee Cave$270K
- Susan CrockettLive Oak$269K
- Henry Garza IiiSan Antonio$258K
- Rene LunaMcAllen$257K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.